G Tremblay

2.6k total citations · 1 hit paper
33 papers, 2.0k citations indexed

About

G Tremblay is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, G Tremblay has authored 33 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 16 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in G Tremblay's work include Lipoproteins and Cardiovascular Health (18 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Cancer, Lipids, and Metabolism (6 papers). G Tremblay is often cited by papers focused on Lipoproteins and Cardiovascular Health (18 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Cancer, Lipids, and Metabolism (6 papers). G Tremblay collaborates with scholars based in Canada, United States and Netherlands. G Tremblay's co-authors include Daniel Gaudet, Isabelle Lemieux, Jean‐Pierre Després, Jean Bergeron, Benoı̂t Lamarche, Denis Prud’homme, André Tchernof, André Nadeau, Agnès Pascot and Natalie Alméras and has published in prestigious journals such as Circulation, Diabetes Care and Clinical Infectious Diseases.

In The Last Decade

G Tremblay

30 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypertriglyceridemic Waist

2000 753 citations Isabelle Lemieux, Benoı̂t Lamarche et al. profile →

Peers

Countries citing papers authored by G Tremblay

Since Specialization

Citations

This map shows the geographic impact of G Tremblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Tremblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Tremblay more than expected).

Fields of papers citing papers by G Tremblay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Tremblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Tremblay. The network helps show where G Tremblay may publish in the future.

Co-authorship network of co-authors of G Tremblay

This figure shows the co-authorship network connecting the top 25 collaborators of G Tremblay. A scholar is included among the top collaborators of G Tremblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Tremblay. G Tremblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of the burden of familial hypercholesterolemia between two cohorts of French Canadians hospitalized 25 years apart for coronary heart disease 2023 ·Journal of clinical lipidology ·(unknown), Diane Brisson, G Tremblay, (unknown), Étienne Khoury, Daniel Gaudet	0
2	Association of common gene-smoking interactions with elevated plasma apolipoprotein B concentration 2020 ·Lipids in Health and Disease ·Nathalie Roy, Daniel Gaudet, G Tremblay, Diane Brisson	1
3	Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemia 2019 ·Expert Opinion on Drug Safety ·Étienne Khoury, Diane Brisson, Nathalie Roy, G Tremblay, Daniel Gaudet	14
4	Comparing Short Form – 6 Dimension (SF-6D) Derived Utilities and Euroqol Questionnaire – 5 Dimensions (EQ-5D) Mapped Utilities Among Patients with Iron Deficiency in Inflammatory Bowel Disease (ID-IBD) Treated with Ferric Maltol (FM) Vs Placebo 2018 ·Value in Health ·G Tremblay, Anna Forsythe, (unknown), Thomas V. Jones	1
5	Angiographically-assessed coronary artery disease associates with HDL particle size in women 2012 ·Atherosclerosis ·Patricia Blackburn, Isabelle Lemieux, Benoı̂t Lamarche, Jean Bergeron, Patrice Perron, G Tremblay, Daniel Gaudet, Jean‐Pierre Després	8
6	Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial 2012 ·Gene Therapy ·Daniel Gaudet, Julie Méthot, S. Déry, Diane Brisson, (unknown), G Tremblay, Karine Tremblay, J. de Wal, Jaap Twisk, N. van den Bulk, (unknown), S van Deventer	302
7	Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in women 2011 ·Metabolism ·Patricia Blackburn, Isabelle Lemieux, Benoı̂t Lamarche, Jean Bergeron, Patrice Perron, G Tremblay, Daniel Gaudet, Jean‐Pierre Després	48
8	Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6–12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms 2010 ·CNS Drugs ·Daniel F. Connor, Robert L. Findling, Scott H. Kollins, Floyd R. Sallee, Frank A. López, A. G. Lyne, G Tremblay	81
9	An Outbreak of Severe Respiratory Tract Infection Due to Human Metapneumovirus in a Long-Term Care Facility 2007 ·Clinical Infectious Diseases ·Guy Boivin, Gaston De Serres, Marie‐Ève Hamelin, S. Côté, (unknown), G Tremblay, (unknown), Chantal Sauvageau, Moussa Ouakki, Nicole Boulianne, Christian Couture	151
10	Genetic Analysis of 103 Candidate Genes for Coronary Artery Disease and Associated Phenotypes in a Founder Population Reveals a New Association between Endothelin-1 and High-Density Lipoprotein Cholesterol 2007 ·The American Journal of Human Genetics ·Guillaume Paré, David Serre, Diane Brisson, Sonia S. Anand, Alexandre Montpetit, G Tremblay, James C. Engert, Thomas J. Hudson, Daniel Gaudet	65
11	Caractérisation de la souplesse des gants de protection par des méthodes mécaniques et une méthode biomécanique basée sur l'électromyographie de surface 2007 ·Espace ÉTS (ETS) ·(unknown), Patricia I. Dolez, (unknown), (unknown), (unknown), G Tremblay, Sylvie Nadeau	1
12	Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia 2006 ·Atherosclerosis ·Tarek Bouhali, Diane Brisson, Julie St‐Pierre, G Tremblay, Patrice Perron, Catherine Laprise, Marie‐Claude Vohl, Maud N. Vissers, Barbara A. Hutten, Jean‐Pierre Després, John J.P. Kastelein, Daniel Gaudet	17
13	Effect of type 2 diabetes on various electrophoretic characteristics of low-density lipoprotein particles in women 2004 ·Diabetologia ·Patricia Blackburn, Isabelle Lemieux, Benoı̂t Lamarche, Jean Bergeron, Patrice Perron, G Tremblay, Daniel Gaudet, (unknown)	8
14	Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease 2002 ·The American Journal of Cardiology ·Julie St‐Pierre, Isabelle Lemieux, Marie‐Claude Vohl, Patrice Perron, G Tremblay, Jean‐Pierre Després, Daniel Gaudet	108
15	A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients 2002 ·Atherosclerosis ·Isabelle Lemieux, Luc Laperrière, Vladimír Džavík, G Tremblay, (unknown), Jean‐Pierre Després	53
16	Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25–49 years) versus middle-aged (50–64 years) men 1999 ·Atherosclerosis ·Daniel Gaudet, Marie‐Claude Vohl, Patrick Couture, Sital Moorjani, G Tremblay, Patrice Perron, Claude Gagné, Jean‐Pierre Després	43
17	Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians 1998 ·The American Journal of Cardiology ·Daniel Gaudet, Marie‐Claude Vohl, Pierre Julien, G Tremblay, Patrice Perron, Claude Gagné, Jean Bergeron, Sital Moorjani, Jean‐Pierre Després	37
18	Geographic distribution of French‐Canadian low‐density lipoprotein receptor gene mutations in the Province of Quebec 1997 ·Clinical Genetics ·Marie‐Claude Vohl, (unknown), Madeleine Roy, Daniel Gaudet, Ana Lucía Torres-Castillo, (unknown), Claude Gagné, G Tremblay, Marie Lambert, Jean Bergeron, Patrick Couture, Patrice Perron, Shirley Blaichman, Louis‐Daniel Brun, Jean Davignon, Paul J. Lupien, Jean‐Pierre Després	35
19	Comparison of the effect of two low‐density lipoprotein receptor class mutations on coronary heart disease among French‐Canadian patients heterozygous for familial hypercholesterolaemia 1997 ·European Journal of Clinical Investigation ·Marie‐Claude Vohl, Daniel Gaudet, Sital Moorjani, G Tremblay, Paul R. Perron, (unknown), (unknown), Jean Bergeron, P J Lupien, JP Després	50
20	Efficacy and Safety of a New Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitor, Atorvastatin, in Patients with Combined Hyperlipidemia: Comparison with Fenofibrate 1997 ·Arteriosclerosis Thrombosis and Vascular Biology ·Teik Chye Ooi, Therèse Heinonen, Petar Alaupovic, Jean Davignon, Lawrence A. Leiter, Paul J. Lupien, Allan D. Sniderman, Meng H. Tan, G Tremblay, Alexander Sorisky, Linda Shurzinske, Donald M. Black	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact